These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 32508322)
1. Prognostic impact of ABO blood group on type I endometrial cancer in a population of Iranian patients. Mohammadian S; Pouresmaeili F; Mohammadian A Hum Antibodies; 2020; 28(4):313-317. PubMed ID: 32508322 [TBL] [Abstract][Full Text] [Related]
2. Is ABO blood group a risk or prognostic factor for patients with endometrioid endometrial cancer? A retrospective analysis in Germany. Gitas G; Proppe L; Alkatout I; Tsolakidis D; Rody A; Kotanidis C; Baum S Blood Transfus; 2020 Nov; 18(6):465-470. PubMed ID: 32530401 [TBL] [Abstract][Full Text] [Related]
3. ABO Blood Group and Endometrial Carcinoma: A Preliminary Single-Center Experience from Saudi Arabia. Abu-Zaid A; Alsabban M; Abuzaid M; Alomar O; Al-Badawi IA; Salem H Cureus; 2017 Dec; 9(12):e1959. PubMed ID: 29487773 [TBL] [Abstract][Full Text] [Related]
4. [Clinical application of adult comorbidity evaluation-27 in endometrial cancer]. Tian WY; Wang YM; Yan Y; Gao JP; Sun DD; Jiang S; Sheng Y; Teng F; Xue FX Zhonghua Fu Chan Ke Za Zhi; 2016 Nov; 51(11):810-817. PubMed ID: 27916063 [No Abstract] [Full Text] [Related]
5. Diagnostic Role of Papanicolaou Smear, Hemoglobin, Blood Group, and Other Clinical Symptoms in Detecting Endometrial Carcinoma: A Clinicopathological Study of 175 Iranian Women with Endometrial Carcinoma. Hosseini MS; Mohammadian S; Farzaneh F; Arab M; Ashrafganjoei T Gynecol Minim Invasive Ther; 2020; 9(3):131-138. PubMed ID: 33101913 [TBL] [Abstract][Full Text] [Related]
6. Preoperative thrombocytosis as a prognostic factor in endometrioid-type endometrial carcinoma. Abu-Zaid A; Alsabban M; Abuzaid M; AlOmar O; Salem H; Al-Badawi IA Ann Saudi Med; 2017; 37(5):393-400. PubMed ID: 28988254 [TBL] [Abstract][Full Text] [Related]
7. Association between ABO blood type and type I endometrial cancer: a retrospective study. Wei S; Yi T; OuYang Z; Wu J J Obstet Gynaecol; 2023 Dec; 43(1):2153026. PubMed ID: 36606697 [TBL] [Abstract][Full Text] [Related]
8. Morphological Spectrum and Pathological Parameters of Type 2 Endometrial Carcinoma: A Comparison With Type 1 Endometrial Cancers. Hashmi AA; Iftikhar SN; Ali J; Shaheen F; Afroze F; Imran A Cureus; 2020 Oct; 12(10):e11025. PubMed ID: 33214953 [TBL] [Abstract][Full Text] [Related]
9. Tumor budding index and microvessel density assessment in patients with endometrial cancer: A pilot study. Kluz T; Łoziński T; Czekierdowska S; Stachowicz N; Gurynowicz G; Chróściel M; Czekierdowski A Oncol Lett; 2020 Sep; 20(3):2701-2710. PubMed ID: 32782586 [TBL] [Abstract][Full Text] [Related]
10. Improved preoperative risk stratification with CA-125 in low-grade endometrial cancer: a multicenter prospective cohort study. Reijnen C; Visser NC; Kasius JC; Boll D; Geomini PM; Ngo H; Van Hamont D; Pijlman BM; Vos MC; Bulten J; Snijders MP; Massuger LF; Pijnenborg JM J Gynecol Oncol; 2019 Sep; 30(5):e70. PubMed ID: 31328454 [TBL] [Abstract][Full Text] [Related]
11. Obesity and Lymphovascular Invasion in Women with Uterine Endometrioid Carcinoma. Kamal M; Burmeister C; Zhang Z; Munkarah A; Elshaikh MA Anticancer Res; 2015 Jul; 35(7):4053-7. PubMed ID: 26124354 [TBL] [Abstract][Full Text] [Related]
12. Comparison of FIGO 1989 and 2009 recommendations on staging of endometrial carcinoma: pathologic analysis and cervical status in 123 consecutive cases. Korczynski J; Jesionek-Kupnicka D; Gottwald L; Piekarski J Int J Gynecol Pathol; 2011 Jul; 30(4):328-34. PubMed ID: 21623209 [TBL] [Abstract][Full Text] [Related]
14. Preoperative Anemia as a Prognostic Factor in Endometrioid-Type Endometrial Carcinoma. Abu-Zaid A; Alsabban M; Abuzaid M; Alomar O; Salem H; Al-Badawi IA J Obstet Gynaecol Can; 2018 Nov; 40(11):1393-1400. PubMed ID: 30473117 [TBL] [Abstract][Full Text] [Related]
15. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer]. Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019 [No Abstract] [Full Text] [Related]
16. Clinicopathologic characteristics and outcomes of endometrial Cancer patients with mismatch repair deficiency in the era of universal Lynch syndrome screening. Carr C; Son J; Yao M; Priyadarshini A; Marquard J; Vargas R; Michener C; AlHilli MM Gynecol Oncol; 2020 Dec; 159(3):712-720. PubMed ID: 33046272 [TBL] [Abstract][Full Text] [Related]
17. ABO and Rh blood groups in relation to ovarian, endometrial and cervical cancer risk among the population of South-East Siberia. Yuzhalin AE; Kutikhin AG Asian Pac J Cancer Prev; 2012; 13(10):5091-6. PubMed ID: 23244116 [TBL] [Abstract][Full Text] [Related]
18. Ten years of experience with endometrial cancer treatment in a single Brazilian institution: Patient characteristics and outcomes. Anton C; Kleine RT; Mayerhoff E; Diz MDPE; Freitas D; Carvalho HA; Carvalho JPM; Silva ASE; Genta MLND; Silva ALFE; Salim RC; Aranha A; Lopez RVM; Carvalho FM; Baracat EC; Carvalho JP PLoS One; 2020; 15(3):e0229543. PubMed ID: 32134921 [TBL] [Abstract][Full Text] [Related]
19. RRBP1 overexpression is associated with progression and prognosis in endometrial endometrioid adenocarcinoma. Liu S; Lin M; Ji H; Ding J; Zhu J; Ma R; Meng F Diagn Pathol; 2019 Jan; 14(1):7. PubMed ID: 30684972 [TBL] [Abstract][Full Text] [Related]
20. Investigation of the effect of ABO blood types on the prognosis of endometrioid-type endometrial cancer. Keser-Şahin HH; Avcı F; Kulhan M; Hamid-Güler A; Can-Ateş M; Çelik Ç; Bilgi A Cir Cir; 2024 Sep; 92(6):808-813. PubMed ID: 39312280 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]